Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.44
Delayed Data
As of May 24
 -0.10 / -2.82%
Today’s Change
2.83
Today|||52-Week Range
7.14
-15.69%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schoeberl Birgit M
Sale7/25/201650,000$5.50$275.0K-37.57%
Porter Michael E
Director
Buy3/10/201785,000$2.69$228.7K+9.21%
Schoeberl Birgit M
Buy7/25/201650,000$2.12$106.0K-37.57%
Stewart Edward J
Buy7/26/201630,000$2.47$74.1K-38.90%
Drummond Daryl
Head of Research
Sale5/12/20174,097$3.72$15.2K-8.75%
Drummond Daryl
Head of Research
Buy5/12/20174,097$2.69$11.0K-8.75%